These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6120758)

  • 1. New antitumor imidazole derivative, 5-carbamoyl-1H-imidazol-4-yl piperonylate, as an inhibitor of purine synthesis and its activation by adenine phosphoribosyltransferase.
    Fukui M; Inaba M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Mar; 42(3):1098-102. PubMed ID: 6120758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collateral sensitivity of 6-mercaptopurine-resistant sublines of P388 and L1210 leukemia to the new purine antagonists, 5-carbamoyl-1H-imidazol-4-yl piperonylate and 4-carbamoylimidazolium 5-olate.
    Inaba M; Fukui M; Yoshida N; Tsukagoshi S; Sakurai Y
    Cancer Res; 1982 Mar; 42(3):1103-6. PubMed ID: 6277474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective reduction of intracellular guanosine 5'-triphosphate pool by 4-carbamoylimidazolium 5-olate in murine tumor cells.
    Fukui M; Inaba M; Tsukagoshi S; Sakurai Y
    Cancer Res; 1986 Jan; 46(1):43-6. PubMed ID: 2866032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phosphoribosylation of 5-fluorouracil by purines.
    Yoshida M; Hoshi A; Kuretani K
    Nucleic Acids Symp Ser; 1980; (8):s175-8. PubMed ID: 6789308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lesch-Nyhan syndrome: the synthesis of inosine 5'-phosphate in the hypoxanthine-guanine phosphoribosyltransferase-deficient erythrocyte by alternate biochemical pathways.
    Lowy BA; Williams MK
    Pediatr Res; 1977 May; 11(5):691-4. PubMed ID: 870876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mode of action of 2-amino-6-chloro-1-deazapurine.
    Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW
    Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
    Hedstrom L; Cheung KS; Wang CC
    Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altering the purine specificity of hypoxanthine-guanine-xanthine phosphoribosyltransferase from Tritrichomonas foetus by structure-based point mutations in the enzyme protein.
    Munagala NR; Wang CC
    Biochemistry; 1998 Nov; 37(47):16612-9. PubMed ID: 9843428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenine phosphoribosyltransferase deficiency in cultured mouse mammary tumor FM3A cells resistant to 4-carbamoylimidazolium 5-olate.
    Koyama H; Kodama H
    Cancer Res; 1982 Oct; 42(10):4210-4. PubMed ID: 7105014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of purine salvage in circumventing the action of antimetabolites in rat hepatoma cells.
    Natsumeda Y; Ikegami T; Olah E; Weber G
    Cancer Res; 1989 Jan; 49(1):88-92. PubMed ID: 2461800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of inhibition of phosphoribosylation of 5-fluorouracil by purines.
    Yoshida M; Hoshi A
    Biochem Pharmacol; 1984 Sep; 33(18):2863-7. PubMed ID: 6206872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor-dependent metabolism of hypoxanthine via the salvage pathway for purine synthesis in porcine aortic endothelial cells.
    Hirai S; Hayashi Y; Koizumi T; Nakanishi N; Fukui T; Ichikawa A
    Biochem Pharmacol; 1993 Apr; 45(8):1695-701. PubMed ID: 7683470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purine salvage in Schistosoma mansoni schistosomules.
    Dovey HF; McKerrow JH; Wang CC
    Mol Biochem Parasitol; 1984 Apr; 11():157-67. PubMed ID: 6431283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2-amino-1,3,4-thiadiazole on ribonucleotide pools of leukemia L1210 cells.
    Nelson JA; Rose LM; Bennett LL
    Cancer Res; 1976 Apr; 36(4):1375-8. PubMed ID: 130972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo synthesis of purine nucleotides in human peripheral blood leukocytes. Excessive activity of the pathway in hypoxanthine-guanine phosphoribosyltransferase deficiency.
    Brosh S; Boer P; Kupfer B; de Vries A; Sperling O
    J Clin Invest; 1976 Aug; 58(2):289-97. PubMed ID: 956368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purine metabolic cycle in normal and leukemic leukocytes.
    Dietz AA; Czebotar V
    Cancer Res; 1977 Feb; 37(2):419-26. PubMed ID: 188545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
    Lucas DL; Webster HK; Wright DG
    J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sensitivity to oxanosine, a novel nucleoside antibiotic, of rat kidney cells upon expression of the integrated viral src gene.
    Uehara Y; Hasegawa M; Hori M; Umezawa H
    Cancer Res; 1985 Nov; 45(11 Pt 1):5230-4. PubMed ID: 2413989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P).
    Moore EC; Hurlbert RB; Boss GR; Massia SP
    Biochem Pharmacol; 1989 Nov; 38(22):4045-51. PubMed ID: 2480792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.